Basic Information
Basic information for TMEM161B-AS1-227-19aa
Peptide Name TMEM161B-AS1-227-19aa
Genome Position chr5:88292886-88292942[+]
Species Human
Peptide Sequence MSYSALRVLFKVVNAQTWN
Peptide Length 19
Unique No (TMEM161B-AS1-215-19aa,TMEM161B-AS1-216-19aa,TMEM161B-AS1-225-19aa,TMEM161B-AS1-230-19aa,TMEM161B-AS1-237-19aa,TMEM161B-AS1-238-19aa,TMEM161B-AS1-241-19aa,TMEM161B-AS1-245-19aa,TMEM161B-AS1-248-19aa,TMEM161B-AS1-254-19aa,TMEM161B-AS1-257-19aa,TMEM161B-AS1-258-19aa)
Grand Average of Hydropathicity 0.2684
Relative Molecular Mass 2551.9
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000658611;TMEM161B-AS1-227
Transcript Length 2228
Coding Ability 0.3299
DNA Sequence Corresponding to Peptide ATGAGCTACAGTGCCCTGAGAGTCCTTTTTAAAGTAGTGAATGCTCAAACATGGAAT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :